New Technique to obtain in a single phase of Growth Factors autolo gos, Thrombin and fibrin gel, to be applied in

摘要

Characterized by a procedure autologous One Phase with small volumes of Blood. Be characterized by Concentrated autologous Growth Factors in Tissue concentrations of biologically active and viable. Characterized by a procedure that obtains high concentrations of autologous Fibrinogen, Thrombin and platelets.Characterized by a physical process with a single centrifugation process standardized 279.5 RCF for 10 minutes. Characterized by a Concentrated autologous free of Erythrocytes, leukocytes and pro-inflammatory factors. Characterized by a Concentrated Risk immunogenic autologous without Eliminating the possibility of immune rejection.Characterized by a Concentrated autologous Without Risk of transmission of viral or Prion Diseases. Characterised by a concentration of fibrin and growth factors, which allows to maintain the viability of the tissue increased vascularization and Oxygenation of tissue rejection, completely discarding the grafts.